Patents Assigned to Adele Health, Inc.
  • Patent number: 12527499
    Abstract: A biological test system has receptacles for a variety of removable electro-mechanical biological blood test-based elements having multiple features such as lancets or strips. Testing is through an analysis biological test processor that provides results to a user test output with all designed to be contained in a pocket-transportable user biological test form factor that houses all elements. Biological test elements can be interchanged for multiple sensing modalities with automatic activation based on cartridge insertion of a glucose test element, an A1C test element, a ketone test element, or the like. Designs can include a user sampler configuration selector for a user sampling selection that may be analyzed so a user-personalizable, biological sampler control processor can automatically disable operation for test safety if a user sampling selection is determined to be unacceptable. The system can also provide a user cartridge action prompt, a user reselection prompt, or other action to clear the disable.
    Type: Grant
    Filed: August 1, 2023
    Date of Patent: January 20, 2026
    Assignee: Adele Health, Inc.
    Inventors: Mark Norton, Gregory Tyler Boyd
  • Patent number: D1116150
    Type: Grant
    Filed: January 31, 2024
    Date of Patent: March 3, 2026
    Assignee: Adele Health, Inc.
    Inventors: Mark Norton, Gregory Tyler Boyd